141 related articles for article (PubMed ID: 35396154)
1. A change in the timing of the Bacillus Calmette-Guérin vaccination in 2013 was associated with an increase in the incidence rate of infants with latent tuberculosis infection.
Hino Y; Eshima N; Tokumaru O; Bacal K; Tanaka Y; Karukaya S; Yamashita Y
J Infect Chemother; 2022 Jul; 28(7):929-933. PubMed ID: 35396154
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study.
Trollfors B; Sigurdsson V; Dahlgren-Aronsson A
Int J Infect Dis; 2021 Aug; 109():279-282. PubMed ID: 34174429
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.
Lule SA; Mawa PA; Nkurunungi G; Nampijja M; Kizito D; Akello F; Muhangi L; Elliott AM; Webb EL
Vaccine; 2015 Feb; 33(6):796-804. PubMed ID: 25529292
[TBL] [Abstract][Full Text] [Related]
4. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of latent tuberculosis infection in rural Jiangsu, China.
Liu Y; Huang S; Jiang H; Xiong J; Wang Y; Ou M; Cai J; Yang C; Wang Z; Ge S; Xia N
Public Health; 2017 May; 146():39-45. PubMed ID: 28404472
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of BCG Vaccination Against Mycobacterium tuberculosis Infection in Adults: A Cross-sectional Analysis of a UK-Based Cohort.
Katelaris AL; Jackson C; Southern J; Gupta RK; Drobniewski F; Lalvani A; Lipman M; Mangtani P; Abubakar I
J Infect Dis; 2020 Jan; 221(1):146-155. PubMed ID: 31504674
[TBL] [Abstract][Full Text] [Related]
7. Ten Years' Experience with the Discontinuation of the Bacillus Calmette-Guérin Vaccination in the Czech Republic.
Doležalová K; Göpfertová D
Int J Mycobacteriol; 2021; 10(2):193-198. PubMed ID: 34558474
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for latent tuberculosis infection in children in South Korea.
Son M; Park YS; Jung MH; Kang JH; Choi UY
Postgrad Med; 2018 Sep; 130(7):637-643. PubMed ID: 30095331
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Treatment Indications, Tuberculin Skin Test, and Bacillus Calmette-Guerin Vaccination Scars in the Cases of Latent Tuberculosis Infection Treatment.
Çakar B
Turk Thorac J; 2018 Jan; 19(1):7-12. PubMed ID: 29404180
[TBL] [Abstract][Full Text] [Related]
11. [Present activity of BCG and LTBI treatment for infants in Japan].
Hoshino H
Kekkaku; 2010 Nov; 85(11):783-6. PubMed ID: 21174734
[TBL] [Abstract][Full Text] [Related]
12. The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study.
Fack C; Wood R; Hatherill M; Cobelens F; Hermans S
Vaccine; 2022 Jan; 40(2):364-369. PubMed ID: 34872798
[TBL] [Abstract][Full Text] [Related]
13. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
[TBL] [Abstract][Full Text] [Related]
14. Specificity of tuberculin skin test improved by BCG immunization schedule change in Japan.
Sakiyama M; Kozaki Y; Komatsu T; Niwa K; Suzuki H; Ota M; Ono Y; Miyagawa Y; Kiyozumi T; Kawana A
J Infect Chemother; 2021 Sep; 27(9):1306-1310. PubMed ID: 33952418
[TBL] [Abstract][Full Text] [Related]
15. Latent tuberculosis infection: Misperceptions among non-U.S.-born-populations from countries where tuberculosis is common.
Parmer J; Macario E; Tatum K; Brackett A; Allen L; Picard R; DeLuca N; Dowling M
Glob Public Health; 2022 Aug; 17(8):1728-1742. PubMed ID: 34228584
[TBL] [Abstract][Full Text] [Related]
16. Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination.
Silver RF; Xia M; Storer CE; Jarvela JR; Moyer MC; Blazevic A; Stoeckel DA; Rakey EK; Tennant JM; Goll JB; Head RD; Hoft DF
Nat Commun; 2023 Dec; 14(1):8507. PubMed ID: 38129388
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of latent tuberculosis infection and its risk factors in schoolchildren and adolescents in Shanghai, China.
Hu Y; Zhao Q; Wu L; Wang W; Yuan Z; Xu B
Eur J Public Health; 2013 Dec; 23(6):1064-9. PubMed ID: 23867560
[TBL] [Abstract][Full Text] [Related]
18. Paediatric tuberculosis during universal and selective
Kontturi A; Kekomäki S; Soini H; Ollgren J; Salo E
Euro Surveill; 2021 Mar; 26(11):. PubMed ID: 33739257
[TBL] [Abstract][Full Text] [Related]
19. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
[TBL] [Abstract][Full Text] [Related]
20. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
